ID: ALA5267429

Max Phase: Preclinical

Molecular Formula: C13H12N2O2

Molecular Weight: 228.25

Associated Items:

Representations

Canonical SMILES:  C[C@H](O)c1nc(O)cc2c1[nH]c1ccccc12

Standard InChI:  InChI=1S/C13H12N2O2/c1-7(16)12-13-9(6-11(17)15-12)8-4-2-3-5-10(8)14-13/h2-7,14,16H,1H3,(H,15,17)/t7-/m0/s1

Standard InChI Key:  NMNFJSMUDNDVKE-ZETCQYMHSA-N

Associated Targets(Human)

NCI-H187 598 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 228.25Molecular Weight (Monoisotopic): 228.0899AlogP: 2.48#Rotatable Bonds: 1
Polar Surface Area: 69.14Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.05CX Basic pKa: 1.83CX LogP: 2.05CX LogD: 2.05
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.60Np Likeness Score: 0.30

References

1. Luo B, Song X..  (2021)  A comprehensive overview of β-carbolines and its derivatives as anticancer agents.,  224  [PMID:34332400] [10.1016/j.ejmech.2021.113688]

Source